New Results
The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care
View ORCID ProfileRichard Croker, Darren Smyth, View ORCID ProfileAlex J Walker, View ORCID ProfileBen Goldacre
doi: https://doi.org/10.1101/266403
Richard Croker
1Honorary Research Fellow, EBM DataLab, Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG
Darren Smyth
2Partner, EIP Europe LLP, Fairfax House, London WC1V 6HU
Alex J Walker
3Researcher, EBM DataLab, Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG
Article usage
Posted February 17, 2018.
The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care
Richard Croker, Darren Smyth, Alex J Walker, Ben Goldacre
bioRxiv 266403; doi: https://doi.org/10.1101/266403
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29194)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18305)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60962)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)